In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 59 for your search:
Cancer Type/Condition:  Cervical cancer
Trial Status:  Active
Sponsor of Trial:  NCI
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: INTERTECC, R21CA162718-01, NCT01554397

2.

Phase: Phase III
Type: Tissue collection/Repository, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: GOG-0263, NCI-2011-02037, CDR0000670125, U10CA027469, NCT01101451

3.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: ANZGOG-0902/GOG-0274/RTOG-1174, NCI-2011-02978, CDR0000706698, GOG-0274, RTOG-1174, ANZGOG-0902, ANZGOG-0902-GOG-0274, U10CA027469, NCT01414608

4.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 1203, CDR0000738944, NCI-2012-02001, NCT01672892

5.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02661, GOG-0076HH, CDR0000693745, U10CA027469, NCT01281852

6.

Phase: Phase II
Type: Behavioral study, Biomarker/Laboratory analysis, Educational/Counseling/Training
Status: Active
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: 2005-4526, R01 CA118136-01A1, NCT00496106

7.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 19 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000579360, UAB-F060511015, UAB-IRB0000196, F060511015, NCT00703196

8.

Phase: Phase II
Type: Treatment
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: CDR0000597154, GOG-0076GG, NCT00691301

9.

Phase: Phase II
Type: Screening
Status: Approved-not yet active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: BCCR-H09-03303, P01CA082710, H09-03303, NCT01094132

10.

Phase: Phase II
Type: Biomarker/Laboratory analysis
Status: Active
Age: 21 to 65
Sponsor: NCI, Other
Protocol IDs: 1P01CA138338, 1P01CA138338-01A1, NCT01158456

11.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: GOG-0265, NCI-2011-02671, CDR0000691288, U10CA027469, NCT01266460

12.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000732629, AMC-081, U01CA121947, NCT01590017

13.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 120116, 12-C-0116, NCT01585428

14.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 5C-11-2, NCI-2012-01378, NCT01676818

15.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02877, PHL-085, 9209, N01CM00071, N01CM00038, N01CM00032, NCT01693783

16.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 201204712, R01CA169336, NCT01717391

17.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00804, NCI 9434, CASE 4812, 9434, U01CA062502, P30CA043703, NCT01835171

18.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Tissue collection/Repository
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MC1267, NCI-2013-00866, P30CA015083, NCT01867606

19.

Phase: Phase I
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000581295, BCCR-H07-01272, P01CA082710, H07-01272, NCT00610662

20.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 to 59
Sponsor: NCI, Other
Protocol IDs: 06-073, R01CA127971, CDR0000629579, GCRC#724, UTMB-06073, IRB#06-073, NCT00878995

21.

Phase: Phase I
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000654177, UPCC-807592, 807592, NCT00978874

22.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 110022, 11-C-0022, NCT01237067

23.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 110061, 11-C-0061, NCT01273168

24.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: GOG-9926, NCI-2011-02665, CDR0000695304, U10CA027469, NCT01295502

25.

Phase: Phase I
Type: Prevention
Status: Active
Age: 18 to 50
Sponsor: NCI, Other
Protocol IDs: 130662, R01CA143130, NCT01653249
1    
New Search